CIK 0001681087
- Non-accelerated filer
- Smaller reporting company
Tectonic Therapeutic, Inc.
Sign in to watch- Ticker
- TECX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- Operating
- EIN
- 810710585
- Phone
- +1 339-666-3320
- Business address
- 490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
- Former names
- AvroBio, Inc., AVROBIO, Inc.
- 4 Shares withheld for taxes Chief Scientific Officer gave up 1,748 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,077 shares (to pay taxes)
- 4 Exercise or conversion Chief Executive Officer acquired 10,966 shares (option exercise)
- 4 Exercise or conversion Chief Scientific Officer acquired 7,000 shares (option exercise)
- 4 Grant or award Chief Business Officer acquired 4,210 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 4,550 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 5,430 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 5,370 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 14,700 shares (grant or award)
- 4 Shares withheld for taxes Chief Executive Officer gave up 859 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 141,923 shares at an average $16.20 ($2,299,015)
- 4 Open-market buy Director bought 500,000 shares at $17.10 ($8,550,000)
- 4 Open-market sale Director sold 500,000 shares at $17.10 ($8,550,000)
- 4 Open-market buy Director bought 789,294 shares at an average $50.68 ($39,999,977)
- 4 Open-market buy Chief Financial Officer bought 4,617 shares at $54.14 ($249,964)
Page 3 of 12 · 226 filings